跳至主要内容
临床试验/NCT04610203
NCT04610203已完成不适用

Glycaemic, Insulinaemic, Gastric Inhibitory Polypeptide (GIP) and Glucagon-like Peptide-1 (GLP-1) Response for Glucose, Glucose With 25 g Nutralys S85 Plus and Glucose With 50 g Nutralys S85 Plus

Oxford Brookes University2 个研究点 分布在 1 个国家目标入组 41 人开始时间: 2018年12月3日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
41
试验地点
2
主要终点
Change in blood glucose response from baseline for 3 hours

研究概览

简要总结

The aim of this study was to compare the glycaemic response, insulinaemic response, GIP response and GLP-1 response to glucose, 25 g Nutralys S85 Plus and 50 g Nutralys S85 Plus using a single-blind, randomised, repeat measure, crossover design trial.

详细描述

The aims of this study were to examine:

  • Phase I - the glycaemic response (GR) and insulinaemic response (IR) to:

  • 50 g available carbohydrate

  • 50 g available carbohydrate + protein (dose 1)

  • 50 g available carbohydrate + protein (dose 2)

  • Phase II - the GLP-1 and GIP response to:

  • 50 g available carbohydrate

  • 50 g available carbohydrate + protein (dose 1)

  • 50 g available carbohydrate + protein (dose 2)

A single-blind, randomised, repeat measure, crossover design trial was used to study the response following consumption of three meals: one reference meal (50 g available carbohydrate) and two test meals (50 g available carbohydrate with protein dose 1 and 50 g available carbohydrate with protein dose 2). The study was conducted in two phases:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Single (Participant)

盲法说明

single-blind

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Aged 18 to 60 years
  • Body mass index (BMI) less than 30kg/m2

排除标准

  • Pregnant or lactating
  • Fasting blood glucose value > 6.1 mmol/l
  • Any known food allergy or intolerance
  • Medical condition(s) or medication(s) known to affect glucose regulation or appetite and/or which influence digestion and absorption of nutrients
  • Known history of diabetes mellitus or the use of antihyperglycaemic drugs or insulin to treat diabetes and related conditions
  • Major medical or surgical event requiring hospitalization within the preceding 3 months
  • Use of steroids, protease inhibitors or antipsychotics (all of which have major effects on glucose metabolism and body fat distribution).
  • Unable to comply with experimental procedures or did not follow GR testing safety guidelines.

结局指标

主要结局

Change in blood glucose response from baseline for 3 hours

时间窗: 3 hours

Change in postprandial blood glucose response from baseline was measured at 15 min, 30 min, 45 min, 1 hour, 1.5 hours, 2 hours, 2.5 hours and 3 hours

Change in plasma insulin response from baseline for 3 hours

时间窗: 3 hours

Change in postprandial plasma insulin response from baseline was measured at 15 min, 30 min, 45 min, 1 hour, 1.5 hours, 2 hours, 2.5 hours and 3 hours

Time of blood glucose peak (Tmax)

时间窗: 0-3 hours

Time of blood glucose peak after consumption of the test food

Peak blood glucose concentration (Cmax)

时间窗: 0-3 hours

Peak blood glucose concentration (Cmax) after consumption of the test food

Area under the plasma insulin concentration versus time curve

时间窗: 3 hours

Area under the plasma insulin concentration versus time curve was calculated by trapezoidal rule

Peak plasma insulin concentration (Cmax)

时间窗: 0-3 hours

Peak plasma insulin concentration (Cmax) after consumption of the test food

Time of plasma insulin peak (Tmax)

时间窗: 0-3 hours

Time of plasma insulin peak after consumption of the test food

Area under the blood glucose concentration versus time curve

时间窗: 3 hours

Area under the blood glucose concentration versus time curve was calculated by trapezoidal rule

次要结局

  • Area under the plasma GIP concentration versus time curve(3 hours)
  • Change in GLP-1 from baseline for 3 hours(3 hours)
  • Change in GIP from baseline for 3 hours(3 hours)
  • Peak plasma GLP-1 concentration (Cmax)(0-3 hours)
  • Peak plasma GIP concentration (Cmax)(0-3 hours)
  • Time of plasma GIP peak (Tmax)(0-3 hours)
  • Area under the plasma GLP-1 concentration versus time curve(3 hours)
  • Time of plasma GLP-1 peak (Tmax)(0-3 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr. Sangeetha Thondre

Principal Investigator

Oxford Brookes University

研究点 (2)

Loading locations...

相似试验